Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black Diamond Therapeutics, Inc.

1.78
+0.08004.71%
Pre-market: 1.75-0.0300-1.69%05:03 EDT
Volume:1.05M
Turnover:1.84M
Market Cap:100.88M
PE:-1.41
High:1.79
Open:1.72
Low:1.71
Close:1.70
Loading ...

Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year

Simply Wall St.
·
Yesterday

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
31 Mar

3 Penny Stocks to Watch Now, 3/20/25

TIPRANKS
·
20 Mar

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires Live
·
20 Mar

Top Midday Gainers

MT Newswires
·
20 Mar

Black Diamond Therapeutics Shares up 36% on Licensing Deal for Tumor Treatment

THOMSON REUTERS
·
19 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Aterian, Autodesk, Ollie's

Reuters
·
19 Mar

Black Diamond Therapeutics Shares up 32.7% Premarket on Licensing Deal for Tumor Treatment

THOMSON REUTERS
·
19 Mar

BUZZ-Black Diamond rises on licensing deal for tumor treatment

Reuters
·
19 Mar

Black Diamond, Servier announce global licensing agreement for BDTX-4933

TIPRANKS
·
19 Mar

BRIEF-Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy

Reuters
·
19 Mar

Black Diamond Therapeutics - to Receive $70 Million Upfront, up to $710 Million in Milestones

THOMSON REUTERS
·
19 Mar

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

GlobeNewswire
·
19 Mar

Black Diamond Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
10 Mar

Black Diamond Therapeutics Reports 2024 Financial Results

TIPRANKS
·
08 Mar

Black Diamond Therapeutics price target lowered to $15 from $16 at Stifel

TIPRANKS
·
07 Mar

Black Diamond Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
07 Mar

Black Diamond Therapeutics Inc : Wedbush Cuts Target Price to $11 From $16

THOMSON REUTERS
·
07 Mar

Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating

MT Newswires Live
·
07 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar